minoxidil and dutasteride

minoxidil has been researched along with dutasteride in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (12.50)29.6817
2010's13 (54.17)24.3611
2020's8 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bandaranayake, I; Mirmirani, P1
Avram, MR; Rogers, NE1
Alsantali, A; Shapiro, J1
Rathnayake, D; Sinclair, R1
Bergstrom, KG1
Banka, N; Bunagan, MJ; Shapiro, J1
Basra, MK; Bhatti, HA; Patel, GK1
Nusbaum, AG; Nusbaum, BP; Rose, PT1
Torres, F1
Ioannides, D; Lazaridou, E1
Cranwell, WC; Sinclair, R1
Blume-Peytavi, U; Blumeyer, A; Del Marmol, V; Dobos, G; Finner, A; Kanti, V; Messenger, A; Nast, A; Piraccini, BM; Reygagne, P; Tosti, A; Trakatelli, M1
Dotzert, MS; Gupta, AK; Mays, RR; Piguet, V; Shear, NH; Versteeg, SG1
Amoh, Y; Inui, S; Itami, S; Ito, T; Kono, T; Kurata, S; Manabe, M; Nakamura, M; Narusawa, H; Ohyama, M; Osada, SI; Saito, N; Sato, A; Shimomura, Y; Tsuboi, R; Ueki, R; Yamazaki, M1
Kochhar, A; Tai, T1
Dommasch, ED; Gao, JL; Peebles, JK; Streed, CG; Thompson, J1
Bamimore, MA; Gupta, AK; Talukder, M; Venkataraman, M1
Boland-Rodriguez, E; Le Voti, F; Rodríguez-León, S; Sinclair, RD; Vano-Galvan, S; Villarreal-Villarreal, CD1
Gómez-Flores, M; Herz-Ruelas, ME; Martínez-Moreno, A; Ocampo-Candiani, J; Ocampo-Garza, J; Ocampo-Garza, SS; Orizaga-Y-Quiroga, TL; Sánchez-Meza, E1
Gupta, AK; Talukder, M; Williams, G1
Domínguez-Santas, M; Grimalt, R; Saceda-Corralo, D; Vañó-Galván, S1
Alhanshali, L; Buontempo, M; Lo Sicco, K; Majerson, D; Shapiro, J1

Reviews

15 review(s) available for minoxidil and dutasteride

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Hair loss remedies--separating fact from fiction.
    Cutis, 2004, Volume: 73, Issue:2

    Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents

2004
Medical treatments for male and female pattern hair loss.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:4

    Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin

2008
Androgens and hair loss.
    Current opinion in endocrinology, diabetes, and obesity, 2009, Volume: 16, Issue:3

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgens; Animals; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Minoxidil; Risk Factors; Testosterone; Treatment Outcome

2009
Male androgenetic alopecia.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:8

    Topics: Administration, Oral; Administration, Topical; Alopecia; Androgen Receptor Antagonists; Azasteroids; Combined Modality Therapy; Dutasteride; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Men's Health; Minoxidil; Polymorphism, Genetic; Receptors, Androgen

2010
Pattern hair loss in men: diagnosis and medical treatment.
    Dermatologic clinics, 2013, Volume: 31, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Azasteroids; Dutasteride; Female; Finasteride; Genetic Predisposition to Disease; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents

2013
Hair restoration approaches for early onset male androgenetic alopecia.
    Journal of cosmetic dermatology, 2013, Volume: 12, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Cosmetic Techniques; Drug Therapy, Combination; Dutasteride; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Tissue and Organ Harvesting; Vasodilator Agents

2013
Nonsurgical therapy for hair loss.
    Facial plastic surgery clinics of North America, 2013, Volume: 21, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Combined Modality Therapy; Dutasteride; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Minoxidil; Sex Factors

2013
Androgenetic, diffuse and senescent alopecia in men: practical evaluation and management.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil; Vasodilator Agents

2015
Female pattern hair loss.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents

2015
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Network Meta-Analysis; Platelet-Rich Plasma; Vasodilator Agents

2018
Physiology and Medical Treatments for Alopecia.
    Facial plastic surgery clinics of North America, 2020, Volume: 28, Issue:2

    Topics: Alopecia; Dihydrotestosterone; Dutasteride; Finasteride; Hair Preparations; Humans; Low-Level Light Therapy; Minoxidil

2020
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
    Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:4

    Topics: Alopecia; Dutasteride; Finasteride; Humans; Minoxidil; Transgender Persons; Treatment Outcome

2023
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
    JAMA dermatology, 2022, Mar-01, Volume: 158, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Bayes Theorem; Dutasteride; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome; Young Adult

2022
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    The Journal of dermatological treatment, 2022, Volume: 33, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil

2022

Trials

1 trial(s) available for minoxidil and dutasteride

ArticleYear
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:10

    Topics: Administration, Topical; Alopecia; Double-Blind Method; Dutasteride; Finasteride; Humans; Minoxidil; Treatment Outcome

2022

Other Studies

8 other study(ies) available for minoxidil and dutasteride

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
    Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:1

    Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors

2011
Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Female; Fibrosis; Folliculitis; Forehead; Humans; Middle Aged; Minoxidil; Prostheses and Implants; Vasodilator Agents

2017
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Therapy, Combination; Dutasteride; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Outcome Assessment, Health Care; Platelet-Rich Plasma; Practice Guidelines as Topic; Vasodilator Agents

2018
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
    The Journal of dermatology, 2018, Volume: 45, Issue:9

    Topics: Adenosine; Administration, Oral; Administration, Topical; Alopecia; Dutasteride; Female; Finasteride; Hair; Humans; Japan; Lasers, Semiconductor; Low-Level Light Therapy; Male; Minoxidil; Sex Factors; Treatment Outcome

2018
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:7

    Topics: Alopecia; Dutasteride; Humans; Male; Microinjections; Minoxidil; Retrospective Studies; Treatment Outcome

2022
What's New in Therapy for Male Androgenetic Alopecia?
    American journal of clinical dermatology, 2023, Volume: 24, Issue:1

    Topics: Alopecia; Dutasteride; Finasteride; Humans; Male; Minoxidil; Retrospective Studies; Treatment Outcome

2023
Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2023, 09-01, Volume: 49, Issue:9

    Topics: Alopecia; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Humans; Mesotherapy; Minoxidil; Treatment Outcome

2023